The role of carboplatin in the neoadjuvant chemotherapy treatment of triple negative breast cancer

• Главные авторы: Aurelio Bartolome Castrellon (Автор), Ihor Pidhorecky (Автор), Vicente Valero (Автор), Luis Estuardo Raez (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2017-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Triple negative breast (TNBC) cancer constitutes a heterogeneous group of disease with histologic and molecular differences. Complete pathologic response to neoadjuvant chemotherapy (NACT) in TNBC is associated with improved outcomes. Efforts have been made in identifying drug combinations that will...